US 10184004
CD47 targeted therapies for the treatment of infectious disease
granted A61KA61K2039/505A61K38/1774
Quick answer
US patent 10184004 (CD47 targeted therapies for the treatment of infectious disease) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K38/1774, A61P, A61P31/12